PROCÉDÉ DE GÉNÉRATION DE COMPOSITIONS THÉRAPEUTIQUES DE CELLULES MODIFIÉES

The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. In some aspects, the provided methods include one or more steps for incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells throug...

Full description

Saved in:
Bibliographic Details
Main Authors LARSON, Ryan P, BEAUCHESNE, Pascal, WESNER, John Matthew, YEE, Nathan, MALLANEY, Mary, BONYHADI, Mark L, LEE, Sarah Y, RAMSBORG, Christopher Glen, WEBER, Clinton, CRISMAN, Ryan L
Format Patent
LanguageFrench
Published 09.09.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. In some aspects, the provided methods include one or more steps for incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells through transduction or transfection, and cultivating the cells under conditions that promote proliferation and/or expansion. In some aspects, the incubation and/or the cultivation is performed in the presence of recombinant IL-2. In some aspects, the provided methods are an efficient, reliable means to produce genetically engineered T cells with a high degree of success.
Bibliography:Application Number: MA20180050855